Global and China Rare Disease Genetic Testing Industry Ecological Development and Analysis Report 2023
Global and China Rare Disease Genetic Testing Industry Ecological Development and Analysis Report 2023
The Rare Disease Genetic Testing study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
In terms of market side, this report researches the Rare Disease Genetic Testing revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
The global Rare Disease Genetic Testing market size in 2022 is 882.1 million US dollars, and it is expected to be 1982.0 million US dollars by 2029, with a compound annual growth rate of 12.26% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Rare Disease Genetic Testing market include Quest Diagnostics Incorporated (U.S.), Centogene N.V. (Germany), Strand Life Sciences (Bengaluru), Ambry Genetics (U.S.), and PerkinElmer, Inc. (U.S.). The share of the top 3 players in the Rare Disease Genetic Testing market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Rare Disease Genetic Testing market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Neurological Disorders accounted for XX% of Rare Disease Genetic Testing market in 2022. Immunological Disorders share of XX%.
Research Laboratories accounted for XX% of the Rare Disease Genetic Testing market in 2022. CROs accounts for XX%.
Report Includes:
This report presents an overview of global market for Rare Disease Genetic Testing. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key players of Rare Disease Genetic Testing, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Rare Disease Genetic Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rare Disease Genetic Testing market share and industry ranking of main players, data from 2018 to 2023. Identification of the major stakeholders in the global Rare Disease Genetic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, from 2018 to 2029. Evaluation and forecast the market size for Rare Disease Genetic Testing sales, projected growth trends, technology, application and end-user industry.
Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions, inflation analysis, and the impact of the Russian-Ukrainian war on the market.
Chapter 2: Analysis of the competitive environment of Rare Disease Genetic Testing market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 3-5: Segmented the global Rare Disease Genetic Testing market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 6: Analyzes the main companies in the Rare Disease Genetic Testing industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 7: Analyzes the Rare Disease Genetic Testing business cost, including industrial chain and the proportion of business cost structure.
Chapter 8: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 9-10: Provide detailed Rare Disease Genetic Testing market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 11: The main points and conclusions of the report.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico
Player list
Quest Diagnostics Incorporated (U.S.)
Centogene N.V. (Germany)
Strand Life Sciences (Bengaluru)
Ambry Genetics (U.S.)
PerkinElmer, Inc. (U.S.)
Macrogen, Inc. (South Korea)
Baylor Genetics (U.S.)
HNL Lab Medicine (U.S.)
Preventiongenetics (U.S.)
3billion, Inc. (South Korea)
Arup Laboratories (U.S.)
HNL Lab Medicine (U.S.)
Preventiongenetics (U.S.)
Invitae Corporation (U.S.)
Eurofins Scientific (Luxembourg)
Strand Life Sciences (India)
Realm IDX, Inc. (China)
Myriad Genetics, Inc. (U.S.)
Laboratory Corporation of America Holdings (U.S.)
Opko Health, Inc. (U.S.)
Types list
Neurological Disorders
Immunological Disorders
Hematology Diseases
Endocrine
Metabolism Diseases
Cancer
Musculoskeletal Disorders
Cardiovascular Disorders (CVDs)
Dermatology Disease
Others
Application list
Research Laboratories
CROs
Diagnostic Centers
Hospitals
Clinics
Table of Content
1 Rare Disease Genetic Testing Market Introduction and Overview
1.1 Rare Disease Genetic Testing Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Rare Disease Genetic Testing Revenue and Market Share by Manufacturer
2.2 Manufacturers Rare Disease Genetic Testing Production Sites, Area Served, Product Types
2.3 Rare Disease Genetic Testing Market Competitive Situation and Trends
2.3.1 Rare Disease Genetic Testing Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Global Rare Disease Genetic Testing Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Rare Disease Genetic Testing Market Share by Type 2018 VS 2022
3.2 Global Rare Disease Genetic Testing Revenue and Market Share by Type
4 Global Rare Disease Genetic Testing Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Rare Disease Genetic Testing Market Share by Application 2018 VS 2022
4.2 Global Rare Disease Genetic Testing Revenue Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global Rare Disease Genetic Testing Market Size (2018-2023)
5.2 Rare Disease Genetic Testing Growth Trends Analysis by Regions
5.2.1 Rare Disease Genetic Testing Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Rare Disease Genetic Testing Historic Revenue Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.3.2 North America SWOT Analysis
5.3.3 United States
5.3.4 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.5.2 Asia Pacific SWOT Analysis
5.5.3 Japan
5.5.4 Korea
5.5.5 Southeast Asia
5.5.6 India
5.5.7 Australia
5.6 EMEA
5.6.1 EMEA Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.6.2 EMEA SWOT Analysis
5.6.3 Europe
5.6.4 Middle East
5.6.5 Africa
5.7 Latin America
5.7.1 Latin America Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.7.2 Latin America SWOT Analysis
5.7.3 Brazil
5.7.4 Argentina
5.7.5 Mexico
6 Players Profiles
6.1 Quest Diagnostics Incorporated (U.S.)
6.1.1 Quest Diagnostics Incorporated (U.S.) Company Profile
6.1.2 Rare Disease Genetic Testing Product Overview
6.1.3 Quest Diagnostics Incorporated (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.1.4 Quest Diagnostics Incorporated (U.S.) Business Overview
6.1.5 SWOT Analysis
6.2 Centogene N.V. (Germany)
6.2.1 Centogene N.V. (Germany) Company Profile
6.2.2 Rare Disease Genetic Testing Product Overview
6.2.3 Centogene N.V. (Germany) Rare Disease Genetic Testing Market Performance (2018-2023)
6.2.4 Centogene N.V. (Germany) Business Overview
6.2.5 SWOT Analysis
6.3 Strand Life Sciences (Bengaluru)
6.3.1 Strand Life Sciences (Bengaluru) Company Profile
6.3.2 Rare Disease Genetic Testing Product Overview
6.3.3 Strand Life Sciences (Bengaluru) Rare Disease Genetic Testing Market Performance (2018-2023)
6.3.4 Strand Life Sciences (Bengaluru) Business Overview
6.3.5 SWOT Analysis
6.4 Ambry Genetics (U.S.)
6.4.1 Ambry Genetics (U.S.) Company Profile
6.4.2 Rare Disease Genetic Testing Product Overview
6.4.3 Ambry Genetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.4.4 Ambry Genetics (U.S.) Business Overview
6.4.5 SWOT Analysis
6.5 PerkinElmer, Inc. (U.S.)
6.5.1 PerkinElmer, Inc. (U.S.) Company Profile
6.5.2 Rare Disease Genetic Testing Product Overview
6.5.3 PerkinElmer, Inc. (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.5.4 PerkinElmer, Inc. (U.S.) Business Overview
6.5.5 SWOT Analysis
6.6 Macrogen, Inc. (South Korea)
6.6.1 Macrogen, Inc. (South Korea) Company Profile
6.6.2 Rare Disease Genetic Testing Product Overview
6.6.3 Macrogen, Inc. (South Korea) Rare Disease Genetic Testing Market Performance (2018-2023)
6.6.4 Macrogen, Inc. (South Korea) Business Overview
6.6.5 SWOT Analysis
6.7 Baylor Genetics (U.S.)
6.7.1 Baylor Genetics (U.S.) Company Profile
6.7.2 Rare Disease Genetic Testing Product Overview
6.7.3 Baylor Genetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.7.4 Baylor Genetics (U.S.) Business Overview
6.7.5 SWOT Analysis
6.8 HNL Lab Medicine (U.S.)
6.8.1 HNL Lab Medicine (U.S.) Company Profile
6.8.2 Rare Disease Genetic Testing Product Overview
6.8.3 HNL Lab Medicine (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.8.4 HNL Lab Medicine (U.S.) Business Overview
6.8.5 SWOT Analysis
6.9 Preventiongenetics (U.S.)
6.9.1 Preventiongenetics (U.S.) Company Profile
6.9.2 Rare Disease Genetic Testing Product Overview
6.9.3 Preventiongenetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.9.4 Preventiongenetics (U.S.) Business Overview
6.9.5 SWOT Analysis
6.10 3billion, Inc. (South Korea)
6.10.1 3billion, Inc. (South Korea) Company Profile
6.10.2 Rare Disease Genetic Testing Product Overview
6.10.3 3billion, Inc. (South Korea) Rare Disease Genetic Testing Market Performance (2018-2023)
6.10.4 3billion, Inc. (South Korea) Business Overview
6.10.5 SWOT Analysis
6.11 Arup Laboratories (U.S.)
6.11.1 Arup Laboratories (U.S.) Company Profile
6.11.2 Rare Disease Genetic Testing Product Overview
6.11.3 Arup Laboratories (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.11.4 Arup Laboratories (U.S.) Business Overview
6.11.5 SWOT Analysis
6.12 HNL Lab Medicine (U.S.)
6.12.1 HNL Lab Medicine (U.S.) Company Profile
6.12.2 Rare Disease Genetic Testing Product Overview
6.12.3 HNL Lab Medicine (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.12.4 HNL Lab Medicine (U.S.) Business Overview
6.12.5 SWOT Analysis
6.13 Preventiongenetics (U.S.)
6.13.1 Preventiongenetics (U.S.) Company Profile
6.13.2 Rare Disease Genetic Testing Product Overview
6.13.3 Preventiongenetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.13.4 Preventiongenetics (U.S.) Business Overview
6.13.5 SWOT Analysis
6.14 Invitae Corporation (U.S.)
6.14.1 Invitae Corporation (U.S.) Company Profile
6.14.2 Rare Disease Genetic Testing Product Overview
6.14.3 Invitae Corporation (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.14.4 Invitae Corporation (U.S.) Business Overview
6.14.5 SWOT Analysis
6.15 Eurofins Scientific (Luxembourg)
6.15.1 Eurofins Scientific (Luxembourg) Company Profile
6.15.2 Rare Disease Genetic Testing Product Overview
6.15.3 Eurofins Scientific (Luxembourg) Rare Disease Genetic Testing Market Performance (2018-2023)
6.15.4 Eurofins Scientific (Luxembourg) Business Overview
6.15.5 SWOT Analysis
6.16 Strand Life Sciences (India)
6.16.1 Strand Life Sciences (India) Company Profile
6.16.2 Rare Disease Genetic Testing Product Overview
6.16.3 Strand Life Sciences (India) Rare Disease Genetic Testing Market Performance (2018-2023)
6.16.4 Strand Life Sciences (India) Business Overview
6.16.5 SWOT Analysis
6.17 Realm IDX, Inc. (China)
6.17.1 Realm IDX, Inc. (China) Company Profile
6.17.2 Rare Disease Genetic Testing Product Overview
6.17.3 Realm IDX, Inc. (China) Rare Disease Genetic Testing Market Performance (2018-2023)
6.17.4 Realm IDX, Inc. (China) Business Overview
6.17.5 SWOT Analysis
6.18 Myriad Genetics, Inc. (U.S.)
6.18.1 Myriad Genetics, Inc. (U.S.) Company Profile
6.18.2 Rare Disease Genetic Testing Product Overview
6.18.3 Myriad Genetics, Inc. (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.18.4 Myriad Genetics, Inc. (U.S.) Business Overview
6.18.5 SWOT Analysis
6.19 Laboratory Corporation of America Holdings (U.S.)
6.19.1 Laboratory Corporation of America Holdings (U.S.) Company Profile
6.19.2 Rare Disease Genetic Testing Product Overview
6.19.3 Laboratory Corporation of America Holdings (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.19.4 Laboratory Corporation of America Holdings (U.S.) Business Overview
6.19.5 SWOT Analysis
6.20 Opko Health, Inc. (U.S.)
6.20.1 Opko Health, Inc. (U.S.) Company Profile
6.20.2 Rare Disease Genetic Testing Product Overview
6.20.3 Opko Health, Inc. (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.20.4 Opko Health, Inc. (U.S.) Business Overview
6.20.5 SWOT Analysis
7 Rare Disease Genetic Testing Business Cost Analysis
7.1 Labor Cost Analysis
7.2 Proportion of Manufacturing Cost Structure
7.3 Rare Disease Genetic Testing Industrial Chain Analysis
8 Rare Disease Genetic Testing Industry Dynamic Analysis
8.1 Rare Disease Genetic Testing Market Trends Analysis
8.2 Rare Disease Genetic Testing Market Drivers Analysis
8.3 Rare Disease Genetic Testing Market Challenges Analysis
8.4 Rare Disease Genetic Testing Market Restraints Analysis
9 Global Rare Disease Genetic Testing Forecast Market Analysis by Type & Application
9.1 Global Rare Disease Genetic Testing Revenue Market Forecast by Type (2023-2029)
9.2 Rare Disease Genetic Testing Revenue Market Forecast by Application (2023-2029)
10 Global Rare Disease Genetic Testing Forecast Market Analysis by Region
10.1 Rare Disease Genetic Testing Revenue Market Forecast by Region (2023-2029)
10.2 North America Rare Disease Genetic Testing Forecast Market Analysis
10.3 EMEA Rare Disease Genetic Testing Forecast Market Analysis
10.4 China Rare Disease Genetic Testing Forecast Market Analysis
10.5 Asia-Pacific Rare Disease Genetic Testing Forecast Market Analysis
10.6 Latin America Rare Disease Genetic Testing Forecast Market Analysis
11 Research Findings and Conclusion
Tables & Figures:
List of Tables and Figures
Figure Rare Disease Genetic Testing Picture
Table Product Definition of Rare Disease Genetic Testing
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Table Global Rare Disease Genetic Testing Revenue ($) by Manufacturer (2018-2023)
Table Global Rare Disease Genetic Testing Revenue Market Share by Manufacturer (2018-2023)
Figure Global Rare Disease Genetic Testing Revenue Market Share by Manufacturer in 2023
Table Manufacturers Rare Disease Genetic Testing Production Sites, Area Served, Product Types
Table Rare Disease Genetic Testing Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2023
Table Mergers & Acquisitions, Expansion Plans
Table Global Rare Disease Genetic Testing Market Size by Type (2023 VS 2029)
Figure Global Rare Disease Genetic Testing Market Share by Type 2018 VS 2022
Table Global Rare Disease Genetic Testing Revenue and Market Size by Type (2018-2023)
Table Global Rare Disease Genetic Testing Revenue and Market Share by Type (2018-2023)
Table Global Rare Disease Genetic Testing Market Size by Application (2023 VS 2029)
Figure Global Rare Disease Genetic Testing Market Share by Application 2018 VS 2022
Table Global Rare Disease Genetic Testing Revenue Market Size by Application (2018-2023)
Table Global Rare Disease Genetic Testing Revenue Market Share by Application (2018-2023)
Figure Global Rare Disease Genetic Testing Revenue Market Size (2018-2023)
Table Rare Disease Genetic Testing Market Size by Regions: 2018 VS 2023 VS 2029
Table Rare Disease Genetic Testing Historic Revenue Market Size by Regions (2018-2023)
Table Rare Disease Genetic Testing Historic Revenue Market Share by Regions (2018-2023)
Figure North America Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table North America Rare Disease Genetic Testing Revenue by Countries (2018-2023)
Table North America Rare Disease Genetic Testing Revenue Market Share by Countries (2018-2023)
Table North America SWOT Analysis
Figure United States Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Canada Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table China SWOT Analysis
Figure China Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Asia Pacific Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table Asia-Pacific Rare Disease Genetic Testing Revenue by Countries (2018-2023)
Table Asia-Pacific Rare Disease Genetic Testing Revenue Market Share by Countries (2018-2023)
Table Asia Pacific SWOT Analysis
Figure Japan Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Korea Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Southeast Asia Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure India Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Australia Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure EMEA Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table EMEA Rare Disease Genetic Testing Revenue by Countries (2018-2023)
Table EMEA Rare Disease Genetic Testing Revenue Market Share by Countries (2018-2023)
Table EMEA SWOT Analysis
Figure Europe Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Germany Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure France Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure UK Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure Italy Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure Russia Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure Nordic Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure Middle East Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Africa Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Latin America Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table Latin America Rare Disease Genetic Testing Revenue by Countries (2018-2023)
Table Latin America Rare Disease Genetic Testing Revenue Market Share by Countries (2018-2023)
Table Latin America SWOT Analysis
Figure Brazil Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Argentina Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Mexico Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table Quest Diagnostics Incorporated (U.S.) Profile
Table Product Overview
Table Quest Diagnostics Incorporated (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Quest Diagnostics Incorporated (U.S.) Revenue and Growth Rate
Figure Quest Diagnostics Incorporated (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Centogene N.V. (Germany) Profile
Table Product Overview
Table Centogene N.V. (Germany) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Centogene N.V. (Germany) Revenue and Growth Rate
Figure Centogene N.V. (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Strand Life Sciences (Bengaluru) Profile
Table Product Overview
Table Strand Life Sciences (Bengaluru) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Strand Life Sciences (Bengaluru) Revenue and Growth Rate
Figure Strand Life Sciences (Bengaluru) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Ambry Genetics (U.S.) Profile
Table Product Overview
Table Ambry Genetics (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Ambry Genetics (U.S.) Revenue and Growth Rate
Figure Ambry Genetics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table PerkinElmer, Inc. (U.S.) Profile
Table Product Overview
Table PerkinElmer, Inc. (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure PerkinElmer, Inc. (U.S.) Revenue and Growth Rate
Figure PerkinElmer, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Macrogen, Inc. (South Korea) Profile
Table Product Overview
Table Macrogen, Inc. (South Korea) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Macrogen, Inc. (South Korea) Revenue and Growth Rate
Figure Macrogen, Inc. (South Korea) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Baylor Genetics (U.S.) Profile
Table Product Overview
Table Baylor Genetics (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Baylor Genetics (U.S.) Revenue and Growth Rate
Figure Baylor Genetics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table HNL Lab Medicine (U.S.) Profile
Table Product Overview
Table HNL Lab Medicine (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure HNL Lab Medicine (U.S.) Revenue and Growth Rate
Figure HNL Lab Medicine (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Preventiongenetics (U.S.) Profile
Table Product Overview
Table Preventiongenetics (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Preventiongenetics (U.S.) Revenue and Growth Rate
Figure Preventiongenetics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table 3billion, Inc. (South Korea) Profile
Table Product Overview
Table 3billion, Inc. (South Korea) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure 3billion, Inc. (South Korea) Revenue and Growth Rate
Figure 3billion, Inc. (South Korea) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Arup Laboratories (U.S.) Profile
Table Product Overview
Table Arup Laboratories (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Arup Laboratories (U.S.) Revenue and Growth Rate
Figure Arup Laboratories (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table HNL Lab Medicine (U.S.) Profile
Table Product Overview
Table HNL Lab Medicine (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure HNL Lab Medicine (U.S.) Revenue and Growth Rate
Figure HNL Lab Medicine (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Preventiongenetics (U.S.) Profile
Table Product Overview
Table Preventiongenetics (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Preventiongenetics (U.S.) Revenue and Growth Rate
Figure Preventiongenetics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Invitae Corporation (U.S.) Profile
Table Product Overview
Table Invitae Corporation (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Invitae Corporation (U.S.) Revenue and Growth Rate
Figure Invitae Corporation (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Eurofins Scientific (Luxembourg) Profile
Table Product Overview
Table Eurofins Scientific (Luxembourg) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Eurofins Scientific (Luxembourg) Revenue and Growth Rate
Figure Eurofins Scientific (Luxembourg) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Strand Life Sciences (India) Profile
Table Product Overview
Table Strand Life Sciences (India) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Strand Life Sciences (India) Revenue and Growth Rate
Figure Strand Life Sciences (India) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Realm IDX, Inc. (China) Profile
Table Product Overview
Table Realm IDX, Inc. (China) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Realm IDX, Inc. (China) Revenue and Growth Rate
Figure Realm IDX, Inc. (China) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Myriad Genetics, Inc. (U.S.) Profile
Table Product Overview
Table Myriad Genetics, Inc. (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Myriad Genetics, Inc. (U.S.) Revenue and Growth Rate
Figure Myriad Genetics, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Laboratory Corporation of America Holdings (U.S.) Profile
Table Product Overview
Table Laboratory Corporation of America Holdings (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Laboratory Corporation of America Holdings (U.S.) Revenue and Growth Rate
Figure Laboratory Corporation of America Holdings (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Opko Health, Inc. (U.S.) Profile
Table Product Overview
Table Opko Health, Inc. (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Opko Health, Inc. (U.S.) Revenue and Growth Rate
Figure Opko Health, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Labor Cost Analysis
Figure Proportion of Manufacturing Cost Structure
Figure Rare Disease Genetic Testing Industrial Chain Analysis
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Global Rare Disease Genetic Testing Revenue Market Size Forecast by Type (2023-2029)
Table Global Rare Disease Genetic Testing Revenue Market Share Forecast by Type (2023-2029)
Table Global Rare Disease Genetic Testing Revenue Market Size by Application (2023-2029)
Table Global Rare Disease Genetic Testing Revenue Market Share by Application (2023-2029)
Table Global Rare Disease Genetic Testing Revenue Market Size by Region (2023-2029)
Table Global Rare Disease Genetic Testing Revenue Market Share by Region (2023-2029)
Figure North America Rare Disease Genetic Testing Forecast Revenue and Growth 2023-2029
Figure EMEA Rare Disease Genetic Testing Forecast Revenue and Growth 2023-2029
Figure China Rare Disease Genetic Testing Forecast Revenue and Growth 2023-2029
Figure Asia-Pacific Rare Disease Genetic Testing Forecast Revenue and Growth 2023-2029
Figure Latin America Rare Disease Genetic Testing Forecast Revenue and Growth 2023-2029
Research Methodology:
Rare Disease Genetic Testing Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|